Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Acetazolamide and Spironolactone to Increase Natriuresis in Congestive Heart Failure (DIURESIS-CHF)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by Hasselt University
Sponsor:
Collaborators:
Ziekenhuis Oost-Limburg
University Hospital Leuven, Leuven, Belgium
Information provided by (Responsible Party):
Wilfried Mullens, MD PhD, Ziekenhuis Oost-Limburg
ClinicalTrials.gov Identifier:
NCT01973335
First received: October 25, 2013
Last updated: October 27, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2018
  Estimated Primary Completion Date: February 2017 (Final data collection date for primary outcome measure)